Key result
Treatment of essential hypertension must be individualized by gender, as women may tolerate hypertension better than men and have unique considerations regarding oral contraceptives and estrogen.
Why the study?
Does gender affect the epidemiology, clinical course, and response to treatment in essential hypertension?
Does gender affect the epidemiology, clinical course, and response to treatment in essential hypertension?
Treatment of hypertension must be individualized with respect to gender, taking into account specific factors such as oral contraceptive use and menopause.
Answers are grounded in this paper and cite their sources.
May support gender-specific hypertension considerations; leaves open need for prospective trials before practice change.
The epidemiology, clinical course, response to treatment, and ultimate outcome of essential hypertension vary as a function of gender. Three early trials on hypertension reported an increase in all-cause mortality in treated white women compared with black women or with men of both races. Later studies, however, suggest that drug therapy has similar and beneficial effects in hypertensive men and women. Women may tolerate hypertension better than do men. Diastolic hypertension correlates with higher mortality from coronary artery disease in men than in women. Special considerations apply to treating the hypertensive woman. Use of oral contraceptives may precipitate or accentuate the problem. In contrast, in the postmenopausal female, estrogen replacement may actually improve hypertension, via several mechanisms. These include the impact of the hormone on vasomotricity, its enhancement of baroreceptor sensitivity, and its impact on the hyperinsulinemia characteristic of menopause. Treatment of hypertension must be individualized with respect to gender. More data on the consequences of treatment of women with hypertension are needed, particularly longterm studies to assess the impact of treatment on mortality.
No takes yet. Share an insight, caveat, or question.
Marianne J. Legato (1998) conducted a review in Essential hypertension. Antihypertensive therapy was evaluated. Treatment of essential hypertension must be individualized by gender, as women may tolerate hypertension better than men and have unique considerations regarding oral contraceptives and estrogen.
Synapse has enriched 10 related papers. Consider them for comparative context: